Showing results (931-940 of 998) with videos related to

Sort By:
Pageof 100
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Plos Genetics|April 26, 2008
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristicsMontserrat Garcia-Closas, Per Hall, Heli Nevanlinna, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
International Journal of Epidemiology|December 13, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysisQi Guo, Stephen Burgess, Constance Turman, et al.
Cancer Research|March 12, 2017
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast CancerHermela Shimelis, Romy L S Mesman, Catharina Von Nicolai, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2024
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk predictionKristia Yiangou, Nasim Mavaddat, Joe Dennis, et al.
Breast Cancer Research : BCR|August 9, 2023
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestryPooja Middha, Xiaoliang Wang, Sabine Behrens, et al.
Breast Cancer Research : BCR|December 29, 2024
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk predictionKristia Yiangou, Nasim Mavaddat, Joe Dennis, et al.
American Journal of Human Genetics|June 16, 2015
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 ExpressionHatef Darabi, Karen McCue, Jonathan Beesley, et al.
Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.
Pageof 100